论文部分内容阅读
目的:探索研究阿普唑仑合并马来酸曲美布汀治疗功能性胃肠病临床疗效。方法:选取2011年5月至2013年8月在我院就诊的功能性胃肠病患者总共106例,随机平均分成试验组和参照组两组。参照组患者使用马来酸曲美布汀进行治疗,试验组患者给予阿普唑仑+马来酸曲美布汀进行治疗,观察两组患者的功能性胃肠病临床效果和情绪状态。结果:试验组患者的总有效率为98.11%,参照组患者的总有效率为79.24%,差异有统计学意义(P<0.05);试验组SAS评分、SDS评分明显低于参照组,差异有统计学意义(P<0.05)。结论:使用阿普唑仑联合马来酸曲美布汀治疗功能性胃肠病具有较好的治疗效果,能够显著缓解患者的功能性胃肠病临床症状,明显改善患者情绪状态,值得临床推广。
Objective: To explore the clinical efficacy of alprazolam combined with trimebutine maleate in the treatment of functional gastrointestinal disease. Methods: A total of 106 patients with functional gastroenterology who were seen in our hospital from May 2011 to August 2013 were randomly divided into experimental group and control group. Patients in the reference group were treated with trimebutine maleate, patients in the test group were given alprazolam and trimebutine maleate, and the clinical efficacy and emotional status of functional gastrointestinal disease in both groups were observed. Results: The total effective rate was 98.11% in the test group and 79.24% in the reference group, the difference was statistically significant (P <0.05); SAS score and SDS score in the experimental group were significantly lower than those in the reference group Statistical significance (P <0.05). Conclusion: Alprazolam combined with trimebutine maleate in the treatment of functional gastrointestinal disease has a good therapeutic effect, which can significantly alleviate the clinical symptoms of patients with functional gastrointestinal disease, significantly improve the emotional state of patients, worthy of clinical promotion .